Page last updated: 2024-09-04

carbapenems and Cystitis

carbapenems has been researched along with Cystitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angoulvant, F; Bontemps, S; Cohen, R; Dessein, R; Dubos, F; Lagree, M; Madhi, F; Martinot, A1
Asadi Karam, MR; Bouzari, S; Habibi, M; Shahbazi, S; Talebi, A1
Naber, KG; Wagenlehner, FME1
Doi, Y; Qureshi, ZA1

Reviews

1 review(s) available for carbapenems and Cystitis

ArticleYear
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
    Expert review of anti-infective therapy, 2014, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States

2014

Other Studies

3 other study(ies) available for carbapenems and Cystitis

ArticleYear
Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Medecine et maladies infectieuses, 2018, Volume: 48, Issue:3

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Cystitis; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospitals, University; Humans; Inappropriate Prescribing; Male; Practice Patterns, Physicians'; Pyelonephritis; Retrospective Studies; Secondary Care Centers; Surveys and Questionnaires; Urinary Tract Infections

2018
Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran.
    Journal of global antimicrobial resistance, 2018, Volume: 14

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Quinolones; Uropathogenic Escherichia coli; Virulence; Virulence Factors; Young Adult

2018
Novel Antibiotics in the Treatment of Urinary Tract Infections.
    European urology focus, 2019, Volume: 5, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections

2019